Status:
COMPLETED
Follow-Up at 6 Years of a Cohort of Children Born Very Prematurely
Lead Sponsor:
Maternite Regionale Universitaire
Conditions:
Premature Birth
Eligibility:
All Genders
6-8 years
Phase:
PHASE4
Brief Summary
Utilization of nitric oxide (NO) therapy has been related to a trend towards short term improvement in very premature infants. A two year follow-up of children treated soon after birth with NO in the ...
Detailed Description
Utilization of nitric oxide therapy in the neonatal period has been related to a trend towards short term improvements in respiratory and neurological outcome at 28 days postnatal age or 36 weeks post...
Eligibility Criteria
Inclusion
- All infants included at birth in a randomized controlled trial using early nitric oxide therapy
Exclusion
- Parental refusal
Key Trial Info
Start Date :
October 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2009
Estimated Enrollment :
108 Patients enrolled
Trial Details
Trial ID
NCT00390065
Start Date
October 1 2006
End Date
June 1 2009
Last Update
March 22 2017
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Maternite Regionale Universitaire
Nancy, France, 54042
2
CHU Brabois
Vandœuvre-lès-Nancy, France, 54500